Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology
Aim of publication. To present recent RGA evidencebased medicine centered guidelines on diagnosis, rational pharmacotherapy and management of irritable bowel syndrome (IBS). Summary. IBS - is a functional bowel disorder is manifested by recurrent abdominal pain that develops at least once per week a...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2018-08-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/184 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860283992440832 |
|---|---|
| author | V. T. Ivashkin Yu. A. Shelygin Ye. K. Baranskaya Ye. A. Belousova A. G. Beniashvili S. V. Vasilyev A. O. Golovenko O. V. Golovenko Ye. G. Grigoryev N. V. Kostenko T. L. Lapina I. D. Loranskaya O. S. Lyashenko I. V. Mayev Ye. A. Poluektova V. G. Rumyantsev V. M. Timerbulatov A. S. Trukhmanov O. Yu. Fomenko I. L. Khalif E. Yu. Chashkova A. A. Sheptulin O. S. Shifrin V. V. Yanovoy |
| author_facet | V. T. Ivashkin Yu. A. Shelygin Ye. K. Baranskaya Ye. A. Belousova A. G. Beniashvili S. V. Vasilyev A. O. Golovenko O. V. Golovenko Ye. G. Grigoryev N. V. Kostenko T. L. Lapina I. D. Loranskaya O. S. Lyashenko I. V. Mayev Ye. A. Poluektova V. G. Rumyantsev V. M. Timerbulatov A. S. Trukhmanov O. Yu. Fomenko I. L. Khalif E. Yu. Chashkova A. A. Sheptulin O. S. Shifrin V. V. Yanovoy |
| author_sort | V. T. Ivashkin |
| collection | DOAJ |
| description | Aim of publication. To present recent RGA evidencebased medicine centered guidelines on diagnosis, rational pharmacotherapy and management of irritable bowel syndrome (IBS). Summary. IBS - is a functional bowel disorder is manifested by recurrent abdominal pain that develops at least once per week and characterized by at least two of the following signs: it is related to bowel movements, associated to the change in stool frequency and/ or shape. These symptoms should be present in the patient for the last 3 months at overall duration of observation for six months or more. Similar to other functional gastrointestinal disorders, the diagnosis of IBS can be established at compliance of symptoms to Rome IV criteria and the absence of organic gastrointestinal diseases that could cause patient’s symptoms. Due to complexity of differential diagnostics, IBS should be considered as diagnosis by exclusion that require following investigations: clinical and biochemical blood tests; IgA or IgG anti-tissue transglutaminase antibodies; thyroid hormone levels; fecal occult blood test; glucose or lactulose hydrogen breath test for bacterial overgrowth syndrome; stool test for coliform bacteria, stool test for Clostridium difficile toxins A and B; fecal calprotectin level; abdominal ultrasound; upper and lower endoscopies, at indications - with biopsies. IBS treatment requires diet and lifestyle modifications, intake of pharmacological agents and psychotherapy. Antispasmodic medications (e.g.: hyoscine butylbromide, pinaverium bromide, mebeverine) are recommended for abdominal pain relief. For diarrhea-predominant IBS such medications as loperamide hydrochloride, dioctaedric smectite, non-absorbable antibiotic rifaximin and probiotics may be prescribed. For treatment of IBS with constipation use of bulking agents (psyllium), osmotic laxatives (macrogol 4000, lactulose), laxatives stimulating intestinal motility (bisacodyl) may be applied. Enterokinetic agent prucalopride may be prescribed at inefficacy of laxatives. Peripheral opioid agonists (trimebutine maleate) normalizing intestinal motor activity via action on different subtypes of peripheral opioid receptors, combined plant-derived medication STW 5 are applied as well. Conclusion. Implementation of clinical guidelines can determine timely diagnosis and treatment of various IBS types. The IBS is characterized by scalloping course with relapse periods that are provoked by psychoemotional stress and remissions. The risk of organic bowel diseases IBS patients is not higher, than in total population. |
| format | Article |
| id | doaj-art-62a2600e038940bc94c51ffa3277975e |
| institution | Kabale University |
| issn | 1382-4376 2658-6673 |
| language | Russian |
| publishDate | 2018-08-01 |
| publisher | Gastro LLC |
| record_format | Article |
| series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| spelling | doaj-art-62a2600e038940bc94c51ffa3277975e2025-02-10T16:14:28ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-01275769310.22416/1382-4376-2017-27-5-76-93184Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctologyV. T. Ivashkin0Yu. A. Shelygin1Ye. K. Baranskaya2Ye. A. Belousova3A. G. Beniashvili4S. V. Vasilyev5A. O. Golovenko6O. V. Golovenko7Ye. G. Grigoryev8N. V. Kostenko9T. L. Lapina10I. D. Loranskaya11O. S. Lyashenko12I. V. Mayev13Ye. A. Poluektova14V. G. Rumyantsev15V. M. Timerbulatov16A. S. Trukhmanov17O. Yu. Fomenko18I. L. Khalif19E. Yu. Chashkova20A. A. Sheptulin21O. S. Shifrin22V. V. Yanovoy23Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityFederal government-financed institution «Ryzhikh State Scientific Center of Coloproctology»Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityState government-financed healthcare institution of the Moscow region «Vladimirsky Moscow regional research clinical institute»Federal government-financed institution «Mental Health Research Center»State educational institution «Saint Petersburg State Pavlov Medical University»Federal government-financed institution «Ryzhikh State Scientific Center of Coloproctology»State educational government-financed institution of continuing professional education «Institute of Postgraduate Medical Education»Federal state government-financed scientific institution «Irkutsk Scientific Center Of Surgery And Traumatology»Federal state government-financed educational institution of higher education «Astrakhan State Medical University»Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityState educational government-financed institution of continuing professional education «Institute of Postgraduate Medical Education»Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityFederal state government-financed educational institution of higher education «Yevdokimov Moscow State University of Medicine and Dentistry»Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityLLC «On-Clinic»Federal state government-financed educational institution of higher education «Bashkir State Medical University»Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityFederal government-financed institution «Ryzhikh State Scientific Center of Coloproctology»Federal government-financed institution «Ryzhikh State Scientific Center of Coloproctology»Federal state government-financed scientific institution «Irkutsk Scientific Center Of Surgery And Traumatology»Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityFederal state government-financed educational institution of higher education «Amur State Medical Academy»Aim of publication. To present recent RGA evidencebased medicine centered guidelines on diagnosis, rational pharmacotherapy and management of irritable bowel syndrome (IBS). Summary. IBS - is a functional bowel disorder is manifested by recurrent abdominal pain that develops at least once per week and characterized by at least two of the following signs: it is related to bowel movements, associated to the change in stool frequency and/ or shape. These symptoms should be present in the patient for the last 3 months at overall duration of observation for six months or more. Similar to other functional gastrointestinal disorders, the diagnosis of IBS can be established at compliance of symptoms to Rome IV criteria and the absence of organic gastrointestinal diseases that could cause patient’s symptoms. Due to complexity of differential diagnostics, IBS should be considered as diagnosis by exclusion that require following investigations: clinical and biochemical blood tests; IgA or IgG anti-tissue transglutaminase antibodies; thyroid hormone levels; fecal occult blood test; glucose or lactulose hydrogen breath test for bacterial overgrowth syndrome; stool test for coliform bacteria, stool test for Clostridium difficile toxins A and B; fecal calprotectin level; abdominal ultrasound; upper and lower endoscopies, at indications - with biopsies. IBS treatment requires diet and lifestyle modifications, intake of pharmacological agents and psychotherapy. Antispasmodic medications (e.g.: hyoscine butylbromide, pinaverium bromide, mebeverine) are recommended for abdominal pain relief. For diarrhea-predominant IBS such medications as loperamide hydrochloride, dioctaedric smectite, non-absorbable antibiotic rifaximin and probiotics may be prescribed. For treatment of IBS with constipation use of bulking agents (psyllium), osmotic laxatives (macrogol 4000, lactulose), laxatives stimulating intestinal motility (bisacodyl) may be applied. Enterokinetic agent prucalopride may be prescribed at inefficacy of laxatives. Peripheral opioid agonists (trimebutine maleate) normalizing intestinal motor activity via action on different subtypes of peripheral opioid receptors, combined plant-derived medication STW 5 are applied as well. Conclusion. Implementation of clinical guidelines can determine timely diagnosis and treatment of various IBS types. The IBS is characterized by scalloping course with relapse periods that are provoked by psychoemotional stress and remissions. The risk of organic bowel diseases IBS patients is not higher, than in total population.https://www.gastro-j.ru/jour/article/view/184синдром раздраженного кишеч-никадиареязапорспазмолитикилоперамида гидрохлориддиоктаэдрический смектитпробио-тикислабительные средствапрукалопридтриме-бутина малеатstw5 |
| spellingShingle | V. T. Ivashkin Yu. A. Shelygin Ye. K. Baranskaya Ye. A. Belousova A. G. Beniashvili S. V. Vasilyev A. O. Golovenko O. V. Golovenko Ye. G. Grigoryev N. V. Kostenko T. L. Lapina I. D. Loranskaya O. S. Lyashenko I. V. Mayev Ye. A. Poluektova V. G. Rumyantsev V. M. Timerbulatov A. S. Trukhmanov O. Yu. Fomenko I. L. Khalif E. Yu. Chashkova A. A. Sheptulin O. S. Shifrin V. V. Yanovoy Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology Российский журнал гастроэнтерологии, гепатологии, колопроктологии синдром раздраженного кишеч-ника диарея запор спазмолитики лоперамида гидрохлорид диоктаэдрический смектит пробио-тики слабительные средства прукалоприд триме-бутина малеат stw5 |
| title | Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology |
| title_full | Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology |
| title_fullStr | Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology |
| title_full_unstemmed | Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology |
| title_short | Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology |
| title_sort | diagnosis and treatment of the irritable bowel syndrome clinical guidelines of the russian gastroenterological association and russian association of coloproctology |
| topic | синдром раздраженного кишеч-ника диарея запор спазмолитики лоперамида гидрохлорид диоктаэдрический смектит пробио-тики слабительные средства прукалоприд триме-бутина малеат stw5 |
| url | https://www.gastro-j.ru/jour/article/view/184 |
| work_keys_str_mv | AT vtivashkin diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT yuashelygin diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT yekbaranskaya diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT yeabelousova diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT agbeniashvili diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT svvasilyev diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT aogolovenko diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT ovgolovenko diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT yeggrigoryev diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT nvkostenko diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT tllapina diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT idloranskaya diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT oslyashenko diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT ivmayev diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT yeapoluektova diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT vgrumyantsev diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT vmtimerbulatov diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT astrukhmanov diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT oyufomenko diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT ilkhalif diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT eyuchashkova diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT aasheptulin diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT osshifrin diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology AT vvyanovoy diagnosisandtreatmentoftheirritablebowelsyndromeclinicalguidelinesoftherussiangastroenterologicalassociationandrussianassociationofcoloproctology |